InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Utter Anders, Director. Director active across 1 company, notably Bioxytran, INC. Cumulatively, 12 filings have been logged. History available since 2 April 2021. The latest transaction was filed on 14 November 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Utter Anders
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
38,588 shares@ US$0.352.5% of flowpreferredSEC:0001445815-25-000008:0
97,535 shares@ US$0.3156.6% of flowpreferredSEC:0001754429-25-000001:0
20,619 shares@ US$0.461.9% of flowpreferredSEC:0001754429-24-000012:0
123,967 shares@ US$0.1213.0% of flowcommonSEC:0001754429-24-000003:0
1,079,189 shares@ US$0.16535.4% of flowcommonSEC:0001754429-24-000003:1
215,838 shares@ US$0.82535.4% of flowpreferredSEC:0001754429-24-000003:2
266,955 shares@ US$0.1146.2% of flowcommonSEC:0001445815-24-000009:0
77,721 shares@ US$0.1933.1% of flowcommonSEC:0001445815-23-000022:0
40,000 shares@ US$0.151.2% of flowcommon stockSEC:0001445815-23-000016:0
30,000 shares@ US$0.4482.7% of flowCommon StockSEC:0001445815-23-000009:0
50,000 shares@ US$0.232.5% of flowCommon StockSEC:0001636357-22-000003:0
30,000 shares@ US$0.170.12% mcap50.0% of flowCommonSEC:0001539497-22-000077:0
12 of 12 declarations
About Utter Anders
Anders Utter is a Director at BIOXYTRAN, INC. In this role, he participates in the governance of the company and strategic decision-making. His experience in the biotechnology sector is valuable in guiding the firm's research and development initiatives.
